192 related articles for article (PubMed ID: 36142647)
21. Amitriptyline inhibits nonalcoholic steatohepatitis and atherosclerosis induced by high-fat diet and LPS through modulation of sphingolipid metabolism.
Lu Z; Li Y; Syn WK; Wang Z; Lopes-Virella MF; Lyons TJ; Huang Y
Am J Physiol Endocrinol Metab; 2020 Feb; 318(2):E131-E144. PubMed ID: 31821039
[TBL] [Abstract][Full Text] [Related]
22. L-Selectin/CD62L is a Key Driver of Non-Alcoholic Steatohepatitis in Mice and Men.
Drescher HK; Schippers A; Rosenhain S; Gremse F; Bongiovanni L; Bruin A; Eswaran S; Gallage SU; Pfister D; Szydlowska M; Heikenwalder M; Weiskirchen S; Wagner N; Trautwein C; Weiskirchen R; Kroy DC
Cells; 2020 Apr; 9(5):. PubMed ID: 32365632
[TBL] [Abstract][Full Text] [Related]
23. Adipsin deficiency does not impact atherosclerosis development in
Liu L; Chan M; Yu L; Wang W; Qiang L
Am J Physiol Endocrinol Metab; 2021 Jan; 320(1):E87-E92. PubMed ID: 33135458
[TBL] [Abstract][Full Text] [Related]
24. Semaglutide Has Beneficial Effects on Non-Alcoholic Steatohepatitis in Ldlr-/-.Leiden Mice.
Inia JA; Stokman G; Morrison MC; Worms N; Verschuren L; Caspers MPM; Menke AL; Petitjean L; Chen L; Petitjean M; Jukema JW; Princen HMG; van den Hoek AM
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239841
[TBL] [Abstract][Full Text] [Related]
25. Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice.
Hasan ST; Zingg JM; Kwan P; Noble T; Smith D; Meydani M
Atherosclerosis; 2014 Jan; 232(1):40-51. PubMed ID: 24401215
[TBL] [Abstract][Full Text] [Related]
26. Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis.
Tølbøl KS; Kristiansen MN; Hansen HH; Veidal SS; Rigbolt KT; Gillum MP; Jelsing J; Vrang N; Feigh M
World J Gastroenterol; 2018 Jan; 24(2):179-194. PubMed ID: 29375204
[TBL] [Abstract][Full Text] [Related]
27. Is Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr-/- Mice Reversible?
Lytle KA; Jump DB
PLoS One; 2016; 11(1):e0146942. PubMed ID: 26761430
[TBL] [Abstract][Full Text] [Related]
28. Complement C5 controls liver lipid profile, promotes liver homeostasis and inflammation in C57BL/6 genetic background.
Bavia L; de Castro ÍA; Cogliati B; Dettoni JB; Alves VA; Isaac L
Immunobiology; 2016 Jul; 221(7):822-32. PubMed ID: 26896155
[TBL] [Abstract][Full Text] [Related]
29. Macrophage migration inhibitory factor deficiency impairs atherosclerosis in low-density lipoprotein receptor-deficient mice.
Pan JH; Sukhova GK; Yang JT; Wang B; Xie T; Fu H; Zhang Y; Satoskar AR; David JR; Metz CN; Bucala R; Fang K; Simon DI; Chapman HA; Libby P; Shi GP
Circulation; 2004 Jun; 109(25):3149-53. PubMed ID: 15197138
[TBL] [Abstract][Full Text] [Related]
30. Myeloid DLL4 Does Not Contribute to the Pathogenesis of Non-Alcoholic Steatohepatitis in Ldlr-/- Mice.
Jeurissen ML; Walenbergh SM; Houben T; Hendrikx T; Li J; Oligschlaeger Y; van Gorp PJ; Gijbels MJ; Bitorina A; Nessel I; Radtke F; Vooijs M; Theys J; Shiri-Sverdlov R
PLoS One; 2016; 11(11):e0167199. PubMed ID: 27898698
[TBL] [Abstract][Full Text] [Related]
31. Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122.
Chai C; Cox B; Yaish D; Gross D; Rosenberg N; Amblard F; Shemuelian Z; Gefen M; Korach A; Tirosh O; Lanton T; Link H; Tam J; Permyakova A; Ozhan G; Citrin J; Liao H; Tannous M; Hahn M; Axelrod J; Arretxe E; Alonso C; Martinez-Arranz I; Betés PO; Safadi R; Salhab A; Amer J; Tber Z; Mengshetti S; Giladi H; Schinazi RF; Galun E
Gastroenterology; 2020 Sep; 159(3):999-1014.e9. PubMed ID: 32450149
[TBL] [Abstract][Full Text] [Related]
32. CD44 is a key player in non-alcoholic steatohepatitis.
Patouraux S; Rousseau D; Bonnafous S; Lebeaupin C; Luci C; Canivet CM; Schneck AS; Bertola A; Saint-Paul MC; Iannelli A; Gugenheim J; Anty R; Tran A; Bailly-Maitre B; Gual P
J Hepatol; 2017 Aug; 67(2):328-338. PubMed ID: 28323124
[TBL] [Abstract][Full Text] [Related]
33. Molecular drivers of non-alcoholic steatohepatitis are sustained in mild-to-late fibrosis progression in a guinea pig model.
Ipsen DH; Skat-Rørdam J; Tsamouri MM; Latta M; Lykkesfeldt J; Tveden-Nyborg P
Mol Genet Genomics; 2019 Jun; 294(3):649-661. PubMed ID: 30759275
[TBL] [Abstract][Full Text] [Related]
34. 2, 3, 4', 5-tetrahydroxystilbene-2-0-β-d Glycoside Attenuates Age- and Diet-Associated Non-Alcoholic Steatohepatitis and Atherosclerosis in LDL Receptor Knockout Mice and Its Possible Mechanisms.
Xu J; Peng Y; Zeng Y; Hua YQ; Xu XL
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30939745
[TBL] [Abstract][Full Text] [Related]
35. Exendin-4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltration.
Wang Y; Parlevliet ET; Geerling JJ; van der Tuin SJ; Zhang H; Bieghs V; Jawad AH; Shiri-Sverdlov R; Bot I; de Jager SC; Havekes LM; Romijn JA; Willems van Dijk K; Rensen PC
Br J Pharmacol; 2014 Feb; 171(3):723-34. PubMed ID: 24490861
[TBL] [Abstract][Full Text] [Related]
36. ARRB1 inhibits non-alcoholic steatohepatitis progression by promoting GDF15 maturation.
Zhang Z; Xu X; Tian W; Jiang R; Lu Y; Sun Q; Fu R; He Q; Wang J; Liu Y; Yu H; Sun B
J Hepatol; 2020 May; 72(5):976-989. PubMed ID: 31857195
[TBL] [Abstract][Full Text] [Related]
37. INT-767 improves histopathological features in a diet-induced
Roth JD; Feigh M; Veidal SS; Fensholdt LK; Rigbolt KT; Hansen HH; Chen LC; Petitjean M; Friley W; Vrang N; Jelsing J; Young M
World J Gastroenterol; 2018 Jan; 24(2):195-210. PubMed ID: 29375205
[TBL] [Abstract][Full Text] [Related]
38. Unraveling the Transcriptional Dynamics of NASH Pathogenesis Affecting Atherosclerosis.
van den Hoek AM; Özsezen S; Caspers MPM; van Koppen A; Hanemaaijer R; Verschuren L
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897797
[TBL] [Abstract][Full Text] [Related]
39. β
Drescher HK; Schippers A; Clahsen T; Sahin H; Noels H; Hornef M; Wagner N; Trautwein C; Streetz KL; Kroy DC
J Hepatol; 2017 Jun; 66(6):1251-1264. PubMed ID: 28192190
[TBL] [Abstract][Full Text] [Related]
40. Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice.
Subramanian S; Goodspeed L; Wang S; Kim J; Zeng L; Ioannou GN; Haigh WG; Yeh MM; Kowdley KV; O'Brien KD; Pennathur S; Chait A
J Lipid Res; 2011 Sep; 52(9):1626-35. PubMed ID: 21690266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]